ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
2,1,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
2,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2,3,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
2,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3,1,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
4,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
5,1,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
5,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
6,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
7,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
8,1,Factor VIII inhibition,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
8,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
9,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
10,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
11,1,Hepatic artery thrombosis,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
11,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
12,1,Renal artery thrombosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
12,2,Retinal vein thrombosis,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
13,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
13,2,Troponin T increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
14,1,Arteriovenous fistula thrombosis,Cardiac and vascular procedural complications,Procedural related injuries and complications NEC,Inj&P,N
15,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
16,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
17,1,Graft thrombosis,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
17,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
17,3,Renal artery thrombosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
17,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
18,1,Cerebral thrombosis,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
19,1,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
20,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
21,1,Pelvic venous thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,Y
21,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
22,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
23,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
23,2,Coronary artery occlusion,Coronary artery disorders NEC,Coronary artery disorders,Card,N
23,3,Electrocardiogram delta waves abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
23,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
23,5,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
23,6,Myocardial necrosis marker increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
23,7,Ventricular dyskinesia,Myocardial disorders NEC,Myocardial disorders,Card,N
24,1,Acute pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
24,2,Left ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
25,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
25,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
25,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
26,1,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
27,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
27,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
28,1,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
29,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
30,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
30,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
31,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
32,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
33,1,Embolic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
34,1,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,Y
35,1,Subclavian vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,Y
36,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
36,2,Peripheral artery thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
37,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
37,2,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
37,3,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
38,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
38,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
39,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
40,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
41,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
42,1,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
42,2,Intestinal infarction,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
42,3,Streptococcal sepsis,Streptococcal infections,Bacterial infectious disorders,Infec,Y
43,1,Abdominal sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
43,2,Hepatic infarction,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
44,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
44,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
44,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
44,4,Ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
44,5,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
45,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
46,1,Enzyme inhibition,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
46,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
47,1,Antibody test positive,Immunology analyses NEC,Immunology and allergy investigations,Inv,N
47,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
48,1,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
49,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
50,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
51,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
52,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
52,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
53,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
53,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
53,3,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
53,4,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,Y
53,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
54,1,Device related sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
54,2,Mesenteric vein thrombosis,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
55,1,Device related sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
55,2,Mesenteric vein thrombosis,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
56,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
57,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
57,2,Vasodilation procedure,Vascular therapeutic procedures NEC,Vascular therapeutic procedures,Surg,N
58,1,Cardiac ventricular thrombosis,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,Y
58,2,Complication associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
59,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
60,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
61,1,Arteriovenous fistula thrombosis,Cardiac and vascular procedural complications,Procedural related injuries and complications NEC,Inj&P,N
62,1,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
63,1,Factor VIII inhibition,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
64,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
65,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
66,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
67,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
68,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
69,1,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
69,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
69,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
70,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
70,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
71,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
71,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
72,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
72,2,Intestinal dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
72,3,Intestinal gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
72,4,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
72,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
72,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
72,7,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
73,1,Factor VIII inhibition,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
73,2,Hepatic artery thrombosis,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,Y
74,1,Abdominal wall haematoma,Abdominal wall conditions NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
74,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
74,3,Intra-abdominal haematoma,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
74,4,Scrotal haematoma,Site specific injuries NEC,Injuries NEC,Inj&P,N
74,5,Wound haemorrhage,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
74,6,Wound haemorrhage,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
75,1,Muscle haemorrhage,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
76,1,Haematoma muscle,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
77,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
77,2,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
78,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
79,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
79,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
80,1,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
81,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
81,2,Superior sagittal sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
82,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
82,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
83,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
83,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
83,3,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
84,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
85,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
85,2,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
85,3,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
86,1,Angina unstable,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
87,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
87,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
88,1,Catheter site thrombosis,Implant and catheter site reactions,Administration site reactions,Genrl,N
89,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
90,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
91,1,Anti-HLA antibody test positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
91,2,Antibody test positive,Immunology analyses NEC,Immunology and allergy investigations,Inv,N
91,3,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
92,1,Infusion site phlebitis,Infusion site reactions,Administration site reactions,Genrl,N
92,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
93,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
94,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
94,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
94,3,Muscle haemorrhage,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
95,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
95,2,Endotracheal intubation,Tracheal therapeutic procedures,Respiratory tract therapeutic procedures,Surg,N
96,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
